Monica F Chen (Monica Chen)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 16

Top Topics

Metastatic Colorectal Cancer

Epidermal Growth Factor Receptor

Human Immunodeficiency Virus

Top Venues

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors. Cancer discovery (2024)
Monica F Chen, Soo-Ryum Yang, Jessica J Tao, Antoine Desilets, Eli L Diamond, Clare J Wilhem, Ezra Y Rosen, Yixiao Gong, Kerry Mullaney, Jean Torrisi, Robert J Young, Romel Somwar, Helena Alexandra Yu, Mark G Kris, Gregory J Riely, Maria E Arcila, Marc Ladanyi, Mark T A Donoghue, Neal X Rosen, Rona Yaeger, Alexander E Drilon, Yonina R Murciano-Goroff, Michael D Offin
Tumor-agnostic genomic and clinical analysis of BRAF fusions identify actionable targets. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Monica F Chen, Soo-Ryum Yang, Jessica J Tao, Antoine Desilets, Eli L Diamond, Clare J Wilhem, Ezra Y Rosen, Yixiao Gong, Kerry Mullaney, Jean Torrisi, Robert J Young, Romel Somwar, Helena Alexandra Yu, Mark G Kris, Gregory J Riely, Maria E Arcila, Marc Ladanyi, Mark T A Donoghue, Neal X Rosen, Rona Yaeger, Alexander E Drilon, Yonina R Murciano-Goroff, Michael D Offin
Tumor-agnostic genomic and clinical analysis of BRAF fusions identify actionable targets. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Noura J Choudhury, Hyung Jun Woo, Monica F Chen, Ronak H Shah, Mark Donoghue, Michael F Berger, Alexander E Drilon
Serial Cell-Free DNA Sequencing in ROS1 Fusion-Positive Lung Cancers During Treatment With Entrectinib. JCO precision oncology 8 (2024)
Noura J Choudhury, Hyung Jun Woo, Monica F Chen, Ronak H Shah, Mark Donoghue, Michael F Berger, Alexander E Drilon
Serial Cell-Free DNA Sequencing in ROS1 Fusion-Positive Lung Cancers During Treatment With Entrectinib. JCO precision oncology 8 (2024)
Monica F Chen, Zihe Song, Helena Alexandra Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Yoshie Umemura, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO precision oncology 8 (2024)
Monica F Chen, Soo-Ryum Yang, Jessica J Tao, Antoine Desilets, Eli L Diamond, Clare J Wilhem, Ezra Y Rosen, Yixiao Gong, Kerry Mullaney, Jean Torrisi, Robert J Young, Romel Somwar, Helena Alexandra Yu, Mark G Kris, Gregory J Riely, Maria E Arcila, Marc Ladanyi, Mark T A Donoghue, Neal X Rosen, Rona Yaeger, Alexander E Drilon, Yonina R Murciano-Goroff, Michael D Offin
Tumor-agnostic genomic and clinical analysis of BRAF fusions identify actionable targets. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Monica F Chen, Soo-Ryum Yang, Jessica J Tao, Antoine Desilets, Eli L Diamond, Clare J Wilhem, Ezra Y Rosen, Yixiao Gong, Kerry Mullaney, Jean Torrisi, Robert J Young, Romel Somwar, Helena Alexandra Yu, Mark G Kris, Gregory J Riely, Maria E Arcila, Marc Ladanyi, Mark T A Donoghue, Neal X Rosen, Rona Yaeger, Alexander E Drilon, Yonina R Murciano-Goroff, Michael D Offin
Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Monica F Chen, Matteo Repetto, Clare Wilhelm, Alexander Drilon
RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future. Drugs (2024)
Monica F Chen, Zihe Song, Helena Alexandra Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Yoshie Umemura, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO precision oncology 8 (2024)
Monica F Chen, Zihe Song, Helena Alexandra Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Yoshie Umemura, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO precision oncology 8 (2024)
Monica F Chen, Soo-Ryum Yang, Jessica J Tao, Antoine Desilets, Eli L Diamond, Clare J Wilhem, Ezra Y Rosen, Yixiao Gong, Kerry Mullaney, Jean Torrisi, Robert J Young, Romel Somwar, Helena Alexandra Yu, Mark G Kris, Gregory J Riely, Maria E Arcila, Marc Ladanyi, Mark T A Donoghue, Neal X Rosen, Rona Yaeger, Alexander E Drilon, Yonina R Murciano-Goroff, Michael D Offin
Tumor-agnostic genomic and clinical analysis of BRAF fusions identify actionable targets. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Monica F Chen, Soo-Ryum Yang, Jinru Shia, Jeffrey Girshman, Sippy Punn, Clare J Wilhem, Mark G Kris, Emiliano Cocco, Alexander E Drilon, Nitya Raj
Response to Repotrectinib After Development of NTRK Resistance Mutations on First- and Second-Generation TRK Inhibitors. JCO precision oncology 7 (2023)